Eton Pharmaceuticals Inc.

15.06
-0.64 (-4.08%)
At close: Mar 03, 2025, 3:59 PM
15.03
-0.20%
After-hours: Mar 03, 2025, 04:00 PM EST

Eton Pharmaceuticals Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 31.64M 21.25M 21.83M 39K 959K n/a n/a
Cost of Revenue 10.58M 6.93M 2.62M 286K 453K 63K 13K
Gross Profit 21.06M 14.32M 19.21M -247K 506K -63K -13K
Operating Income -1.19M -8.26M -1.5M -27.11M -18.6M -10.32M -7.15M
Interest Income n/a 761K 1.01M 859K 281K 164K 52.5K
Pretax Income -689K -9.02M -1.96M -27.97M -18.32M -12.74M -7.16M
Net Income -936K -9.78M -2.96M -28.83M -18.04M -12.74M -7.16M
Selling & General & Admin 18.93M 18.58M 14.47M 12.76M 7.55M 4.69M 3.21M
Research & Development 3.32M 4M 6.24M 14.1M 11.55M 5.63M 3.93M
Other Expenses n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 22.25M 22.58M 20.7M 26.86M 19.11M 10.32M 7.14M
Interest Expense n/a 955K 1.01M 889K n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a -1.62M
Cost & Expenses 32.83M 29.51M 23.33M 27.15M 19.56M 10.32M 7.15M
Income Tax 247K 761K 1.01M 859K -281K -2.58M n/a
Shares Outstanding (Basic) 25.64M 25.15M 25.21M 21.01M 17.76M 6.42M 17.46M
Shares Outstanding (Diluted) 25.65M 25.15M 25.21M 21.01M 17.76M 6.42M 17.46M
EPS (Basic) -0.04 -0.39 -0.12 -1.37 -1.02 -1.99 -0.41
EPS (Diluted) -0.04 -0.39 -0.12 -1.37 -1.02 -1.99 -0.41
EBITDA -291K -6.49M -1.12M -26.46M -18.15M -10.26M -7.14M
Depreciation & Amortization 901K 1.76M 447K 651K 447K 63K 13K